Investment & funding
Endogenex has raised US$50m to complete development of its diabetes procedure and take the technology to the FDA. The fundraising comes shortly after the company delivered initial clinical study results showing its pulsed electric field system met safety goals and led to metabolic improvements in HbA1c, fasting glucose levels and body weight. Founded in partnership [...]
A new report by Clue has revealed the ‘Cost of Bleeding’ - a deep dive into the true cost of menstruation and the impact of related expenses adding up year after year. The consumer research reveals that, on average, respondents spend an estimated £41 on their cycle each month, amounting to an astounding £20,359 across [...]
A vision implant firm has raised US$230m as it seeks approval in Europe and the US for a device that restored sight in a small clinical trial. The Alameda, California-based startup said the funding would support commercialisation of its Prima device. It said an upcoming launch is planned in Europe and that it would become [...]
Sleep apnoea costs the UK and US economies more than £137bn a year, with researchers calling for workplace screening and earlier treatment. The condition causes repeated pauses in breathing during sleep. People often snore loudly, wake gasping for air and experience severe daytime tiredness. If untreated, it raises the risk of heart attack and stroke. [...]
Nyra health has raised €20m to scale its digital neurotherapy platform for neurological rehabilitation, targeting conditions such as stroke and dementia. The Series A funding will be used to expand the company’s technology across the DACH region, accelerate its expansion into the US and support a more data-driven approach to neurorehabilitation. Founded in 2021, Vienna-based [...]
NIH funding of US$80m will support further research into exceptional longevity, continuing a long-running study of families whose members live far longer than statistical models predict. The funding renews support for the Long Life Family Study, an international project tracking multiple generations, including people who have lived to 100 and beyond. Researchers are seeking genetic [...]
Astellas has agreed a US$1.7bn global prostate cancer deal with Vir Biotechnology to develop a masked T-cell engager designed to harness the immune system against the disease. The collaboration centres on VIR-5500, a PSMAxCD3 bispecific drug known as a T-cell engager, or TCE. TCEs activate immune cells called T cells and direct them to attack [...]
Eye care startup Custom Surgical has raised €3.5m to modernise ophthalmology by turning analogue slit lamps and microscopes into digital data hubs. Munich-based Custom Surgical was founded in 2018 by mechatronics engineer Federico Acosta and Fernando Benito. It specialises in digitalising slit lamps and surgical microscopes used in everyday eye care. Slit lamps are standard [...]
Korsana Biosciences has emerged from stealth with US$175m to develop an Alzheimer’s antibody designed to boost amyloid plaque clearance. The Waltham, Massachusetts-based biotech is focused on neurodegenerative disease. Its lead programme, KRSA-028, is a next-generation shuttled monoclonal antibody targeting amyloid beta, a protein that can build up into plaques in Alzheimer’s. The treatment uses the [...]
Regenerative innovator's cash boost, are biological clocks out of time?, Y chromosome concerns, £60bn of graft by UK pensioners Indian regenerative medicine company Pandorum Technologies, has raised US$18m in a Series B funding round to support its clinical developments and global expansion. The company, which operates the United States as well as its domestic market, [...]
